BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17060876)

  • 1. Choroidal neovascularization with interferon associated retinopathy: case report and review of literature.
    Bazarah SM; Ritenour R; Patel ST; Hirsch G; Peltekian KM; Cruess AF
    Ann Hepatol; 2006; 5(3):172-6. PubMed ID: 17060876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pegylated interferon and ribavirin associated retinopathy in patients with hepatitis C].
    Burgueño-Montañés C; Pérez-Álvarez R
    Arch Soc Esp Oftalmol; 2011 Jun; 86(6):193-5. PubMed ID: 21767697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Severe ocular bacterial infection associated with pegylated interferon and ribavirin treatment for hepatitis C].
    Khalil A; Gonzalez F; El Riachy E; Lucidarme D; Filoche B
    Gastroenterol Clin Biol; 2005 Nov; 29(11):1187-8. PubMed ID: 16505773
    [No Abstract]   [Full Text] [Related]  

  • 4. [Retinopathy in a patient with hepatitis C treated with pegylated interferon and ribavirin: case report].
    Avila MP; Freitas AM; Isaac DL; Bastos AL; Pena RV
    Arq Bras Oftalmol; 2006; 69(2):255-9. PubMed ID: 16699680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe interstitial pneumonitis secondary to pegylated interferon alpha-2b and ribavirin treatment of hepatitis C infection.
    Fuhrmann V; Kramer L; Bauer E; Laferl H; Tucek G; Dekan G; Schenk P
    Dig Dis Sci; 2004; 49(11-12):1966-70. PubMed ID: 15628735
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pegylated-interferon-associated retinopathy].
    Pérez-Alvarez MJ; Montes-Ramírez ML; Machín-Lázaro JM; Rodríguez-Zapata M
    Enferm Infecc Microbiol Clin; 2007 Mar; 25(3):217. PubMed ID: 17335705
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C.
    Okuse C; Yotsuyanagi H; Nagase Y; Kobayashi Y; Yasuda K; Koike K; Iino S; Suzuki M; Itoh F
    World J Gastroenterol; 2006 Jun; 12(23):3756-9. PubMed ID: 16773695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is screening for interferon retinopathy in hepatitis C justified?
    Cuthbertson FM; Davies M; McKibbin M
    Br J Ophthalmol; 2004 Dec; 88(12):1518-20. PubMed ID: 15548803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C: a review of diagnosis, management, and ocular complications from treatment.
    Tsolakos A; Zalatimo N
    Optometry; 2003 Aug; 74(8):517-23. PubMed ID: 12926825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin.
    Kim ET; Kim LH; Lee JI; Chin HS
    Jpn J Ophthalmol; 2009 Nov; 53(6):598-602. PubMed ID: 20020238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pegylated interferon and ribavirin-induced interstitial pneumonitis with ARDS.
    Abi-Nassif S; Mark EJ; Fogel RB; Hallisey RK
    Chest; 2003 Jul; 124(1):406-10. PubMed ID: 12853555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ischemic neuroretinopathy associated with use of interferon].
    Miserachs-García S; Mesa-Toledo E; Arruga-Ginebreda J; Castillo-Campillo L
    Arch Soc Esp Oftalmol; 2005 Sep; 80(9):533-5. PubMed ID: 16193437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interferon-related retinopathy in a man with chronic hepatitis C].
    Viennet A; Glatre F; Bacin F
    J Fr Ophtalmol; 2009 Sep; 32(7):505-10. PubMed ID: 19592135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin.
    Fouad YM; Khalaf H; Ibraheem H; Rady H; Helmy AK
    Int J Infect Dis; 2012 Jan; 16(1):e67-71. PubMed ID: 22115957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2b and ribavirin for recurrent hepatitis C.
    Mukherjee S
    J Gastroenterol Hepatol; 2004 Jun; 19(6):723-4. PubMed ID: 15151639
    [No Abstract]   [Full Text] [Related]  

  • 16. Is combination therapy interferon and ribavirin in patients with chronic hepatitis C infection toxic for eyes?
    Mousa N; Besheer T; Gad Y; Elbendary A; Mokbel T; Abdel-Aziz A
    J Ocul Pharmacol Ther; 2013 Apr; 29(3):345-8. PubMed ID: 23113644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catatonia associated with pegylated interferon-α 2b and ribavirin for hepatitis C.
    Quinn D; Kuchler E; Deming P; Arora S
    Psychosomatics; 2012; 53(4):400-1. PubMed ID: 22748752
    [No Abstract]   [Full Text] [Related]  

  • 18. Pegylated interferon-associated retinopathy in chronic hepatitis C patients.
    Ogata H; Suzuki H; Shimizu K; Ishikawa H; Izumi N; Kurosaki M
    Jpn J Ophthalmol; 2006; 50(3):293-5. PubMed ID: 16767392
    [No Abstract]   [Full Text] [Related]  

  • 19. [Healing hepatitis C infections. Pegylated interferon alfa-2a opens new perspectives].
    MMW Fortschr Med; 2003 Jun; 145(26):52-3. PubMed ID: 12916339
    [No Abstract]   [Full Text] [Related]  

  • 20. Interferon alfa, peginterferon alfa and retinopathy.
    Prescrire Int; 2006 Apr; 15(82):61-2. PubMed ID: 16607695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.